News

News
Partner news

Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL

Read full story
Partner news

Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza

Read full story
Partner news

Philogen Announces Options Exercise by Janssen

Read full story
Partner news

RefleXion Raises $100 Million for Cancer Treatment Commercialization

Read full story
Partner news

Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies

Read full story
Partner news

Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform

Read full story
Partner news

HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Read full story
Partner news

BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140

Read full story
Partner news

Joint Purification Systems, Inc. Announces $7.8 Million Series A Financing

Read full story
Partner news

ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications

Read full story
Partner news

ViaCyte Awarded NIH SBIR Grant to Support In Vitro Development of Stem Cell-Derived Functional Human Pancreatic Beta Cells

Read full story
Partner news

RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment

Read full story
Partner news

Aelix Therapeutics appoints HIV expert as CMO

Read full story
Partner news

Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer

Read full story
Partner news

Padlock Therapeutics Assembles Scientific Advisory Board with World Leaders in PAD Enzyme Biology and Autoimmune Disease

Read full story